| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Accurately addressing double-arm-zero-events studies in meta-analyses
|
Zhou, Qi
|
|
|
25 |
3 |
p. e92
|
artikel
|
| 2 |
Accurately addressing double-arm-zero-events studies in meta-analyses – Authors' reply
|
Fujiwara, Yu
|
|
|
25 |
3 |
p. e93
|
artikel
|
| 3 |
Activity and safety of enobosarm, a novel, oral, selective androgen receptor modulator, in androgen receptor-positive, oestrogen receptor-positive, and HER2-negative advanced breast cancer (Study G200802): a randomised, open-label, multicentre, multinational, parallel design, phase 2 trial
|
Palmieri, Carlo
|
|
|
25 |
3 |
p. 317-325
|
artikel
|
| 4 |
Androgen receptor agonism in advanced oestrogen receptor-positive breast cancer
|
Chen, Nan
|
|
|
25 |
3 |
p. 269-270
|
artikel
|
| 5 |
Antibody–drug conjugates in acute myeloid leukaemia: more research needed
|
Kayser, Sabine
|
|
|
25 |
3 |
p. 272-273
|
artikel
|
| 6 |
A pan-European total cancer prevalence canvas: a benchmark for advancing strategic interventions
|
Shariat, Shahrokh F
|
|
|
25 |
3 |
p. 266-267
|
artikel
|
| 7 |
BRCA testing launched for people of Jewish ancestry in England
|
Venkatesan, Priya
|
|
|
25 |
3 |
p. 284
|
artikel
|
| 8 |
CALLA trial: immunotherapy in locally advanced cervical cancer
|
Kouhen, Fadila
|
|
|
25 |
3 |
p. e94
|
artikel
|
| 9 |
CALLA trial: immunotherapy in locally advanced cervical cancer
|
Yang, Xi
|
|
|
25 |
3 |
p. e95
|
artikel
|
| 10 |
CALLA trial: immunotherapy in locally advanced cervical cancer – Authors' reply
|
Monk, Bradley J
|
|
|
25 |
3 |
p. e96
|
artikel
|
| 11 |
Children and Young People Cancer Taskforce
|
Burki, Talha
|
|
|
25 |
3 |
p. e103
|
artikel
|
| 12 |
Complete cancer prevalence in Europe in 2020 by disease duration and country (EUROCARE-6): a population-based study
|
De Angelis, Roberta
|
|
|
25 |
3 |
p. 293-307
|
artikel
|
| 13 |
Correction to Lancet Oncol 2023; 24: 483–95
|
|
|
|
25 |
3 |
p. e102
|
artikel
|
| 14 |
Data sharing in cancer research: perceived risks and the consequences of not sharing
|
Topham, James T
|
|
|
25 |
3 |
p. 275-276
|
artikel
|
| 15 |
Deep-learning-based reconstruction of undersampled MRI to reduce scan times: a multicentre, retrospective, cohort study
|
Rastogi, Aditya
|
|
|
25 |
3 |
p. 400-410
|
artikel
|
| 16 |
Design and implementation of a humanitarian cancer care programme for Ukrainian refugees in Moldova and Romania
|
Vulpe, Horia
|
|
|
25 |
3 |
p. 289-291
|
artikel
|
| 17 |
Endpoints in human papillomavirus-related oropharyngeal cancer trials
|
Posner, Marshall
|
|
|
25 |
3 |
p. 270-272
|
artikel
|
| 18 |
Harnessing stereotactic precision in the fight against primary kidney cancer: time for a randomised trial?
|
Yang, Daniel X
|
|
|
25 |
3 |
p. 267-269
|
artikel
|
| 19 |
Horizon 2020 evaluation highlights benefit of cross-border research but points to areas for improvement
|
Wilkinson, Emma
|
|
|
25 |
3 |
p. 282-283
|
artikel
|
| 20 |
HPV vaccination programme success in Scotland
|
Burki, Talha
|
|
|
25 |
3 |
p. 281
|
artikel
|
| 21 |
IAEA site visit to the Zaporizhzhya Nuclear Power Plant in Ukraine
|
Das, Manjulika
|
|
|
25 |
3 |
p. 280
|
artikel
|
| 22 |
Joseph Lubega, Director of Global HOPE—building paediatric cancer care in sub-Saharan Africa
|
Wilkinson, Emma
|
|
|
25 |
3 |
p. 292
|
artikel
|
| 23 |
Lessons learned from postmarketing withdrawals of expedited approvals for oncology drug indications
|
Koole, Simone N
|
|
|
25 |
3 |
p. e126-e135
|
artikel
|
| 24 |
Non-surgical ablation for breast cancer: an emerging therapeutic option
|
Toi, Masakazu
|
|
|
25 |
3 |
p. e114-e125
|
artikel
|
| 25 |
Optimal imaging before local therapy of colorectal liver metastases
|
Granata, Vincenza
|
|
|
25 |
3 |
p. e100
|
artikel
|
| 26 |
Optimal imaging before local therapy of colorectal liver metastases
|
Haddad, Antony
|
|
|
25 |
3 |
p. e99
|
artikel
|
| 27 |
Optimal imaging before local therapy of colorectal liver metastases – Authors' reply
|
Görgec, Burak
|
|
|
25 |
3 |
p. e101
|
artikel
|
| 28 |
Paraneoplastic dermatoses in a patient with gastric adenocarcinoma: cutaneous clues to internal malignancy
|
Chen, Tai-Li
|
|
|
25 |
3 |
p. e136
|
artikel
|
| 29 |
Pivekimab sunirine (IMGN632), a novel CD123-targeting antibody–drug conjugate, in relapsed or refractory acute myeloid leukaemia: a phase 1/2 study
|
Daver, Naval G
|
|
|
25 |
3 |
p. 388-399
|
artikel
|
| 30 |
Radiotherapy trial quality assurance processes: a systematic review
|
Brooks, Chloe
|
|
|
25 |
3 |
p. e104-e113
|
artikel
|
| 31 |
Safe and effective cancer care: how long must we wait?
|
The Lancet Oncology,
|
|
|
25 |
3 |
p. 265
|
artikel
|
| 32 |
Stereotactic ablative body radiotherapy for primary kidney cancer (TROG 15.03 FASTRACK II): a non-randomised phase 2 trial
|
Siva, Shankar
|
|
|
25 |
3 |
p. 308-316
|
artikel
|
| 33 |
Strategies to promote sustainable care for children with cancer in Ukraine
|
Agulnik, Asya
|
|
|
25 |
3 |
p. 285-288
|
artikel
|
| 34 |
Substance use disorders among cancer survivors
|
Devi, Sharmila
|
|
|
25 |
3 |
p. 279
|
artikel
|
| 35 |
Surrogate endpoints in clinical trials of p16-positive squamous cell carcinoma of the oropharynx: an individual patient data meta-analysis
|
Gharzai, Laila A
|
|
|
25 |
3 |
p. 366-375
|
artikel
|
| 36 |
Tabelecleucel for allogeneic haematopoietic stem-cell or solid organ transplant recipients with Epstein–Barr virus-positive post-transplant lymphoproliferative disease after failure of rituximab or rituximab and chemotherapy (ALLELE): a phase 3, multicentre, open-label trial
|
Mahadeo, Kris Michael
|
|
|
25 |
3 |
p. 376-387
|
artikel
|
| 37 |
The multitarget faecal immunochemical test for improving stool-based colorectal cancer screening programmes: a Dutch population-based, paired-design, intervention study
|
Wisse, Pieter H A
|
|
|
25 |
3 |
p. 326-337
|
artikel
|
| 38 |
The need for speed: recovering undersampled MRI scans for glioma imaging
|
Barkhof, Frederik
|
|
|
25 |
3 |
p. 274-275
|
artikel
|
| 39 |
The Radiation Planning Assistant: addressing the global gap in radiotherapy services
|
Court, Laurence E
|
|
|
25 |
3 |
p. 277-278
|
artikel
|
| 40 |
Uncovering causal clues in the development of second primary cancers
|
Yi, Huan
|
|
|
25 |
3 |
p. e97
|
artikel
|
| 41 |
Uncovering causal clues in the development of second primary cancers – Authors' reply
|
Kjaer, Trille Kristina
|
|
|
25 |
3 |
p. e98
|
artikel
|
| 42 |
Use of chemotherapy in patients with oesophageal, stomach, colon, rectal, liver, pancreatic, lung, and ovarian cancer: an International Cancer Benchmarking Partnership (ICBP) population-based study
|
McPhail, Sean
|
|
|
25 |
3 |
p. 338-351
|
artikel
|
| 43 |
Use of radiotherapy in patients with oesophageal, stomach, colon, rectal, liver, pancreatic, lung, and ovarian cancer: an International Cancer Benchmarking Partnership (ICBP) population-based study
|
McPhail, Sean
|
|
|
25 |
3 |
p. 352-365
|
artikel
|
Tijdschrift beschrijving